These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 12351647)

  • 1. An ephrin mimetic peptide that selectively targets the EphA2 receptor.
    Koolpe M; Dail M; Pasquale EB
    J Biol Chem; 2002 Dec; 277(49):46974-9. PubMed ID: 12351647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
    Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
    J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering nanomolar peptide ligands that differentially modulate EphA2 receptor signaling.
    Gomez-Soler M; Petersen Gehring M; Lechtenberg BC; Zapata-Mercado E; Hristova K; Pasquale EB
    J Biol Chem; 2019 May; 294(22):8791-8805. PubMed ID: 31015204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity.
    Koolpe M; Burgess R; Dail M; Pasquale EB
    J Biol Chem; 2005 Apr; 280(17):17301-11. PubMed ID: 15722342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
    Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
    J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization.
    Ogawa K; Pasqualini R; Lindberg RA; Kain R; Freeman AL; Pasquale EB
    Oncogene; 2000 Dec; 19(52):6043-52. PubMed ID: 11146556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pinpointed Stimulation of EphA2 Receptors via DNA-Templated Oligovalence.
    Möser C; Lorenz JS; Sajfutdinow M; Smith DM
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship analysis of peptides targeting the EphA2 receptor.
    Mitra S; Duggineni S; Koolpe M; Zhu X; Huang Z; Pasquale EB
    Biochemistry; 2010 Aug; 49(31):6687-95. PubMed ID: 20677833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation.
    Brantley-Sieders DM; Caughron J; Hicks D; Pozzi A; Ruiz JC; Chen J
    J Cell Sci; 2004 Apr; 117(Pt 10):2037-49. PubMed ID: 15054110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
    Fang WB; Brantley-Sieders DM; Hwang Y; Ham AJ; Chen J
    J Biol Chem; 2008 Jun; 283(23):16017-26. PubMed ID: 18387945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
    Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
    PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sizes of interface residues account for cross-class binding affinity patterns in Eph receptor-ephrin families.
    Guo FY; Lesk AM
    Proteins; 2014 Mar; 82(3):349-53. PubMed ID: 24105818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A small peptide promotes EphA2 kinase-dependent signaling by stabilizing EphA2 dimers.
    Singh DR; Pasquale EB; Hristova K
    Biochim Biophys Acta; 2016 Sep; 1860(9):1922-8. PubMed ID: 27281300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
    Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells.
    Zhou N; Zhao WD; Liu DX; Liang Y; Fang WG; Li B; Chen YH
    Microvasc Res; 2011 Sep; 82(2):113-21. PubMed ID: 21726568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Architecture of Eph receptor clusters.
    Himanen JP; Yermekbayeva L; Janes PW; Walker JR; Xu K; Atapattu L; Rajashankar KR; Mensinga A; Lackmann M; Nikolov DB; Dhe-Paganon S
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):10860-5. PubMed ID: 20505120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation.
    Miao H; Burnett E; Kinch M; Simon E; Wang B
    Nat Cell Biol; 2000 Feb; 2(2):62-9. PubMed ID: 10655584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand recognition by A-class Eph receptors: crystal structures of the EphA2 ligand-binding domain and the EphA2/ephrin-A1 complex.
    Himanen JP; Goldgur Y; Miao H; Myshkin E; Guo H; Buck M; Nguyen M; Rajashankar KR; Wang B; Nikolov DB
    EMBO Rep; 2009 Jul; 10(7):722-8. PubMed ID: 19525919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly.
    Seiradake E; Harlos K; Sutton G; Aricescu AR; Jones EY
    Nat Struct Mol Biol; 2010 Apr; 17(4):398-402. PubMed ID: 20228801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis.
    Nakamoto M; Bergemann AD
    Microsc Res Tech; 2002 Oct; 59(1):58-67. PubMed ID: 12242697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.